Examination of unmet treatment needs among persons with episodic migraine: Results of the American Migraine prevalence and prevention (AMPP) study

Headache

Volumn 53, Issue 8, 2013, Pages 1300-1311

  Lipton, Richard B ^a,b   Buse, Dawn C ^a,b   Serrano, Daniel ^c   Holland, Starr ^d   Reed, Michael L ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c VEDANTA RESEARCH   (United States)

^d Armstrong State University   (United States)

Author keywords

acute treatment; cardiovascular risk factors; headache related disability; migraine; satisfaction; unmet need

Indexed keywords

BARBITURIC ACID DERIVATIVE; OPIATE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DEPRESSION; DISEASE CLASSIFICATION; EMERGENCY WARD; EPISODIC MIGRAINE; FEMALE; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDER 2ND EDITION; MAJOR CLINICAL STUDY; MALE; MIDAS (MIGRAINE); PATIENT SATISFACTION; PERCEPTION; PREVALENCE; PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ACUTE TREATMENT; CARDIOVASCULAR RISK FACTORS; HEADACHE-RELATED DISABILITY; MIGRAINE; SATISFACTION; UNMET NEED;

ADULT; COHORT STUDIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POPULATION SURVEILLANCE; PREVALENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 84884145492     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12154     Document Type: Article

References (21)

1. Monteith TS, Goadsby PJ,. Acute migraine therapy: New drugs and new approaches. Curr Treat Options Neurol. 2011; 13: 1-14.
2. Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC,. Barriers to the diagnosis and treatment of migraine: Effects of sex, income and headache features. Headache. 2013; 53: 81-92.
3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M,. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001; 41: 646-657.
4. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF,. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68: 343-349.
5. Gibbs TS, Fleischer AB, Feldman SR, et al. Health care utilization in patients with migraine: Sociodemographics and patterns of care in the ambulatory setting. Headache. 2003; 43: 330-335.
6. Silberstein SD,. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762.
7. Davis KH, Black L, Sleath B,. Validation of the Patient Perception of Migraine Questionnaire. Value Health. 2002; 5: 422-430.
8. Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB,. Opioid use and dependence among persons with migraine: Results of the AMPP study. Headache. 2012; 52: 18-36.
9. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004; 24: 483-490.
10. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
11. Stewart WF, Lipton RB, Celentano DD, Reed ML,. Prevalence of migraine headache in the United States: Relation to age, income, race, and other sociodemographic factors. JAMA. 1992; 267: 64-69.
12. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
13. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J,. Reliability of the Migraine Disability Assessment Score in a population-based sample of headache sufferers. Cephalalgia. 1999; 19: 107-114.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press; 2000.
15. BMI calculator. http://www.exrx.net/Calculators/BMI.html.
16. Spitzer RL, Kroenke K, Williams JBW, for the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999; 282: 1737-1744.
17. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
18. Patrick DL, Martin ML, Bushnell DM, Pesa J,. Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings. Clin Ther. 2003; 25: 2920-2935.
19. Horton M, Rudick RA, Hara-Cleaver C, Marrie RA,. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010; 35: 83-90.
20. McKenzie JA, Cutrer FM,. How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine. Headache. 2009; 49: 669-672.
21. El Hasnaoui A, Vray M, Blin P, Nachit-Ouinekh F, Boureau F,; HEMISHERE study group. Assessment of migraine severity using the MIGSEV scale: Relationship to migraine features and quality of life. Cephalalgia. 2004; 24: 262-270.